ERT for Rare Genetic Disorders
Enzyme Replacement Therapy provides patients with the enzymes their bodies cannot produce or produce in insufficient quantities. This essential treatment helps manage rare genetic disorders known as lysosomal storage diseases.
Enzyme Replacement Therapy involves intravenous infusion of manufactured enzymes to replace or supplement enzymes that are missing or deficient. These enzymes are produced using recombinant DNA technology.
These rare inherited conditions occur when the body lacks enzymes needed to break down certain substances. Without treatment, harmful materials accumulate in cells, causing progressive organ damage.
Enzyme replacement therapy is the standard of care for several rare genetic disorders.
Caused by deficiency of glucocerebrosidase, leading to accumulation of fatty substances in the spleen, liver, and bone marrow.
Caused by deficiency of alpha-galactosidase A, causing progressive damage to the heart, kidneys, and nervous system.
Caused by deficiency of acid alpha-glucosidase (GAA), affecting muscles including the heart and respiratory muscles.
A group of conditions where the body cannot properly break down mucopolysaccharides, including Hunter and Hurler syndromes.
Our nurses are trained in all FDA-approved enzyme replacement therapies
For Gaucher Disease
For Fabry Disease
For Pompe Disease
For Hunter Syndrome
For MPS I
For LAL Deficiency
Since ERT requires regular infusions every 1-2 weeks, home treatment offers significant advantages for patients and families.
Receive treatment in your familiar environment
Infusions scheduled around your life
Dedicated nurse throughout your infusion
Avoid exposure to clinical settings